AFP and hepatocellular carcinoma: Currently, screening for HCC is based on serum alpha-fetoprotein measurements, imaging techniques, and tissue biopsies.[3,4] The current diagnoses of early-stage HCC remain limited because AFP testing cannot validate atypical results while not detecting all patients along with imaging devices which struggle with small lesions.